Reuters logo
5 months ago
BRIEF-Mylan says no comment at this point on U.S. generic Advair application
March 29, 2017 / 11:44 AM / 5 months ago

BRIEF-Mylan says no comment at this point on U.S. generic Advair application

March 29 (Reuters) - Mylan:

* Spokeswoman says company has no comment at this point on its U.S. FDA application for generic copy of GlaxoSmithKline's Advair

* For more on this story see Further company coverage: (Reporting by Ben Hirschler)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below